About the parameter
A small amount of protein is excreted daily into the urine of healthy individuals. These extracted proteins are so called mucoproteins, most of which are filtered out of the uriniferous tubules and the glomeruli. Albumin, however, is a protein that is not easily filtered out and is excreted into the urine (microalbuminuria).
Microalbuminuria is a condition characterised by increased urinary excretion of albumin in the absence of overt nephropathy. Microalbumin has been reported in several studies to predict development of diabetic nephropathy and its mortality risk in diabetic patients. Because microalbuminuria may be reversible if diabetes is well controlled, the early detection of Microalbumin can prove very beneficial in treatment programs for diabetes.
The facts mentioned above make albumin excretion into the urine a useful indicator of early glomerular disease.
Antigen-antibody reaction test. Turbidity measurement at 700 nm.
Urine: 0.5 mg/dl – 30 mg/dl
24h urine: 5 mg/l – 300 mg/l
Test takes approximately 6 minutes.
More details can be found in the package insert.
Please note: All package inserts provided on this website are intended for information purposes only! Always process all tests, controls and calibrators strictly according to the package insert provided with the kit.
Find the evaluation study for the Eurolyser Microalbumin assay (in German!) here: Evaluation Eurolyser Microalbumin
Please note: depending on the time of the market launch of an assay, the respective assay evaluation was carried out using either a Eurolyser smart instrument or a Eurolyser CUBE instrument.
Since the measurement method is the same in both instruments (their photometric units are identical in construction), as was proved in this comparison study, all testkit evaluations provided on this website are valid for either instrument!
ST 0130 Microalbumin test kit (containing 32 tests)
ST 1300 Microalbumin control kit (low/high)
18. August 2020
SDMA: A new veterinary assay for evaluation of chronic kidney diseases...» Read more...
17. August 2020
Phenobarbital: A next generation epilepsy monitoring assay...» Read more...
10. December 2019
Launch of bidirectional connectivity: a feature for CUBE series instruments...» Read more...
5. December 2019